#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    PIK3CA related overgrowth spectrum Glomerulonephritis membranoproliferative Nephropathy Hypersomnia Aplastic anaemia Angiosarcoma metastatic Raynaud's phenomenon Malignant fibrous histiocytoma Infertility male Thyroid cancer metastatic Palmar-plantar erythrodysaesthesia syndrome Ependymoma Amyotrophic lateral sclerosis Juvenile psoriatic arthritis T-cell lymphoma More trials…

    Learn about Rare Diseases

    Wolfram syndrome – Life with Disease Shprintzen-Goldberg syndrome Chondrosarcoma metastatic Mucous membrane pemphigoid Short-bowel syndrome – Diagnostics Von Willebrand’s disease – Treatment Uterine leiomyosarcoma Soft tissue sarcoma – Basic Information Fragile X syndrome – Treatment Mitochondrial myopathy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GRISNILIMAB SETARITOX Vibegron Camlipixant Daplusiran Brexucabtagene Autoleucel Almagate RO7268489 Inupadenant Hydrochloride Mrna-4157 Ursodeoxycholic Acid Hydroxypropyl Cellulose Lf Bleomycin Sulfate Ph. Eur. Triptorelin Rp-1664 Sulfate Sotalol Levothyroxine Sodium Human Albumin Solution Anhydrous Docetaxel Ketoprofen Lysine Trimethoprim More therapies…

    Learn about Your Condition

    Infection Toxic epidermal necrolysis Choreoathetosis Aicardi-Goutieres syndrome Heparin resistance Periarthritis Metastatic neoplasm Neuroendocrine carcinoma Hypotension Gastrectomy Fragile X syndrome Hernia repair Notalgia paraesthetica Niemann-Pick disease Critical illness More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Phaeochromocytoma

  • A study of belzutifan and lenvatinib for patients with von Hippel-Lindau disease-associated tumors or other specific solid tumors.

    Recruiting

    3 1 1
    Investigated Drugs:
    • Belzutifan
    • Lenvatinib
    Belgium Czechia Denmark Finland France Germany +4

  • Evaluation of D-Glucose-13C6 Test for Detecting SDHx Mutations in Patients with Pheochromocytoma or Paraganglioma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Paraganglion neoplasm
    • Phaeochromocytoma
    France

  • Study on the Effectiveness of Lutetium (177Lu) Edotreotide for Patients with Neuroendocrine Tumors and Other SSTR-Positive Tumors

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Neuroendocrine tumour
    • Paraganglion neoplasm
    • Phaeochromocytoma
    Investigated Drugs:
    • Lutetium (177Lu) Edotreotide
    Italy

  • Study on [18F]mFBG PET-CT Imaging for Patients with Pheochromocytoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Phaeochromocytoma
    Investigated Drugs:
    • M-(18F)-Fluorobenzylguanidine
    The Netherlands

  • Study on the Safety of Lutetium (177Lu) Oxodotreotide, L-Lysine Hydrochloride, and L-Arginine Hydrochloride in Adolescents with Neuroendocrine Tumors and PPGLs

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroendocrine tumour
    • Gastroenteropancreatic neuroendocrine tumour disease
    • Paraganglion neoplasm
    Investigated Drugs:
    • Lutetium (177Lu) Oxodotreotide
    • L-Arginine Hydrochloride
    • L-Lysine Hydrochloride
    France Poland Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!